Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 251–254 of 254 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00501306	Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men	completed	—	195	Laser Surgery CareOTHER	1	Jun 23, 2011	clinicaltrials
NCT01104181	Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test	completed	N/A	300	Laser Surgery CareOTHER	1	Jun 22, 2011	clinicaltrials